Fiduciary & Transparent Pharmacy Benefits Manager (PBM)
Better Outcomes and Lower Cost
Experience the power of our fiduciary commitment driving every aspect of our pharmacy benefit risk management services. The time for change is now. No conflicts of interest, no misaligned profit incentives, no benefit constraints, no waste, and full transparency in your pharmacy benefit. Accept nothing less.
Better Health Outcomes and Lower Cost
Experience the power of our fiduciary commitment driving every aspect of our pharmacy benefit risk management services. The time for change is now. No conflicts of interest, no misaligned profit incentives, no benefit constraints, no waste, and full transparency in your pharmacy benefit. Accept nothing less.
The US-Rx Care Difference
Over 30 years of experience managing pharmacy risk for health plans, self-insured employers, and union health & welfare funds.
Contractual adherence to fiduciary standards on behalf of plan sponsors and plan enrollees.
Quality of care and service obsessed.
No financial conflicts of interest, no hidden profits, unrestricted transparency.
US-Rx Care is honored to be independently verified by the Validation Institute for:
Contractual integrity and transparency
Notable cost savings over traditional PBMs
Positive clinical outcomes
Find Your Ideal Savings Solution
Client Success
Learn how US-Rx Care helped a 600-employee manufacturing company reduce pharmacy benefits costs by 50% in 12 months.
Learn how US-Rx Care helped Vensure Employer Services create satisfied clients.
Case Studies
Explore the Latest News and Resources from US-Rx Care
Health Plans Covering Fewer Drugs, Imposing More Restrictions
As prescription drug costs continue growing and pricey new pharmaceuticals add to health plans'...
Study Predicts 8% Group Health Plan Cost Increase for 2025
A new study predicts that group health insurance costs will jump 8% in 2025, on par with what American employers have experienced this year and in 2023.
The higher rates reflect the costs borne by health insurers, which are seeing more claims for care that was postponed during the COVID-19 pandemic and a steady rise in the cost of pharmaceuticals as more innovative and effective drugs come to market, according to the study. There are also a few new cost drivers, which are counterbalanced by the potential for savings thanks to some new developments.
Addictions Are Rising Among Workers; What Employers Can Do
According to a study by the Substance Abuse and Mental Health Services Administration, 10% of...